• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 21st, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
General view of the statue of late Pope John Paul II and Gemelli Hospital, where Pope Francis is admitted for ongoing pneumonia treatment, in Rome, Italy, March 10, 2025.
General view of the statue of late Pope John Paul II and Gemelli Hospital, where Pope Francis is admitted for ongoing pneumonia treatment, in Rome, Italy, March 10, 2025.
An image depicting Pope Francis and a sheet of paper that reads 'Come on Pope Francis' are placed at the statue of late Pope John Paul II outside Gemelli Hospital where Pope Francis is admitted to continue treatment for ongoing pneumonia, in Rome, Italy, March 10, 2025.
An image depicting Pope Francis and a sheet of paper that reads 'Come on Pope Francis' are placed at the statue of late Pope John Paul II outside Gemelli Hospital where Pope Francis is admitted to continue treatment for ongoing pneumonia, in Rome, Italy, March 10, 2025.
People pray near the statue of late Pope John Paul II outside Gemelli Hospital where Pope Francis is admitted for ongoing pneumonia treatment, in Rome, Italy, March 10, 2025.
People pray near the statue of late Pope John Paul II outside Gemelli Hospital where Pope Francis is admitted for ongoing pneumonia treatment, in Rome, Italy, March 10, 2025.
Home
Business
Healthcare & Pharmaceuticals

Pope Francis responding well to treatment, prognosis no longer guarded, Vatican says

March 10th, 2025 | 18:59 PM BUSINESS Healthcare & Pharmaceuticals 2

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Michigan cyclosporiasis cases rise by 368 in a week to 14,277
India's Manipal Health sees adjusted quarterly profit jump on strong demand for complex care
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says
Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak
By Joshua McElwee

Pope Francis is responding well to treatment in hospital and his doctors have decided his prognosis is no longer guarded, the Vatican said on Monday, in a sign of progress as the 88-year-old pontiff battles double pneumonia.

Francis has been in Rome's Gemelli hospital for more than three weeks. He was admitted on February 14 with a severe respiratory infection that has required evolving treatment.

"The clinical conditions of the Holy Father continue to be stable," said the latest detailed medical update.

"The improvements recorded in previous days have further consolidated, as confirmed by both blood tests and clinical assessments, as well as a good response to his drug treatments," it said.

As a result, the pope's doctors, have decided to lift their earlier "guarded" prognosis the Vatican said, but they expect Francis "to continue medical drug treatment in a hospital setting for further days."

No exact time frame was given for his discharge.

Francis had been under the "guarded" prognosis, meaning he was not out of imminent danger, for most of his hospital stay.

The pope has been described as being in a stable or improving condition for the past week, following two crises of "acute respiratory insufficiency" on March 3.

The Vatican said earlier on Monday that Francis was continuing with his treatment and was undergoing respiratory physiotherapy to help with his breathing.

The pontiff, who has used a wheelchair in recent years due to knee and back pain, also continued with some physical therapy to help with mobility, it said.

The pope is receiving oxygen in hospital, using a small oxygen hose under his nose during the day and non-invasive mechanical ventilation at night while he sleeps.

The pope has experienced several bouts of ill health over the last two years and is prone to lung infections because he had pleurisy as a young adult and had part of one lung removed.

Double pneumonia is a serious infection in both lungs that can inflame and scar them, making it difficult to breathe.

  • Topic
  • POPE
  • FRANCIS/HEALTH (UPDATE 1, PIX)
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Michigan cyclosporiasis cases rise by 368 in a week to 14,277

Related Posts

Healthcare & Pharmaceuticals
August 20th, 2026

Michigan cyclosporiasis cases rise by 368 in a week to 14,277

Healthcare & Pharmaceuticals
August 20th, 2026

India's Manipal Health sees adjusted quarterly profit jump on strong dem...

Healthcare & Pharmaceuticals
August 20th, 2026

Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, W...

Healthcare & Pharmaceuticals
August 20th, 2026

Green giant: How Taylor Farms became a top salad supplier before US diar...

Healthcare & Pharmaceuticals
August 20th, 2026

Congo's M23 rebels introduce new movement restrictions over Ebola concer...

Healthcare & Pharmaceuticals
August 20th, 2026

First screwworm case detected in Mexican state of Sonora

The Wire
Aug 21st 3 h ago
Science

China hunts for lunar ice in one of solar system's coldest ...

Aug 20th 3 h ago
Asia Pacific

Japan July core CPI rises 1.8% yr/yr

Aug 20th 4 h ago
Government

DOJ seeks to question FBI officials tied to search of Trump...

Aug 20th 4 h ago
Sports

Cowboys, Saints each fined $500K for brawling at joint prac...

Aug 20th 4 h ago
Asia Pacific

Japan's core inflation accelerates in July, bolsters case f...

TRENDING ON FINANCETIME
Aug 20th, 2026 United Kingdom

UK consumer confidence jumps to two-year high, GfK says

Aug 20th, 2026 India

Focus: AI reshapes India's IT services sector contracts as clients demand more for less

Aug 20th, 2026 China

China, Indonesia ministers meet on Friday, to discuss security and economic issues

Aug 20th, 2026 Government

Ex-Google engineer's conviction for stealing AI secrets partially overturned    

Aug 20th, 2026 Sports

NFL committees recommend approval of $9.6B Seahawks sale

Markets-Sectors
TECHNOLOGY -0.29%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT